These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4152317)

  • 1. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
    Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 4. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.
    Azzaro AJ; Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1974 Apr; 189(1):110-8. PubMed ID: 4823286
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of d-amphetamine and potassium on serotonin release and metabolism in rat cerebral cortex tissue.
    Homan HD; Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):223-40. PubMed ID: 6164082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain.
    Rutledge CO
    J Pharmacol Exp Ther; 1970 Feb; 171(2):188-95. PubMed ID: 5413739
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
    Simpson LL
    J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on the effect of p-hydroxynorephedrine (PONE) on norepinephrine metabolism in the rat brain.
    Hitzemann RJ; Loh HH
    Eur J Pharmacol; 1974 Jun; 27(1):89-98. PubMed ID: 4859338
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
    Rutledge CO; Azzaro AJ; Ziance RJ
    Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of amphetamine-induced release of norepinephrine from rat cerebral cortex in vitro.
    Ziance RJ; Azzaro AJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Aug; 182(2):284-94. PubMed ID: 5048365
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
    Liang NY; Hower JA; Borchardt RT
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 18. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
    Jain M; Bakutis E; Gayle T; Lansky P
    Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
    [No Abstract]   [Full Text] [Related]  

  • 19. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
    Azzaro AJ; Rutledge CO
    Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.